Boston Operating Income vs Total Operating Expenses Analysis

BSX Stock

USD 90.75 0.54 0.60%

Boston Scientific financial indicator trend analysis is way more than just evaluating Boston Scientific Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Boston Scientific Corp is a good investment. Please check the relationship between Boston Scientific Operating Income and its Total Operating Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Operating Income vs Total Operating Expenses

Operating Income vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Boston Scientific Corp Operating Income account and Total Operating Expenses. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Boston Scientific's Operating Income and Total Operating Expenses is 0.57. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Boston Scientific Corp, assuming nothing else is changed. The correlation between historical values of Boston Scientific's Operating Income and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Boston Scientific Corp are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Operating Income i.e., Boston Scientific's Operating Income and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.57

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Operating Income

Operating Income is the amount of profit realized from Boston Scientific Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Boston Scientific Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most indicators from Boston Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

At this time, Boston Scientific's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 679.4 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.29 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	8.1B	8.7B	9.9B	10.4B
Total Revenue	11.9B	12.7B	14.2B	15.0B

Gross Profit Total Revenue

Boston Scientific fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Short Term Investments
Total Assets		0.96	0.78	0.73	0.97	0.99	0.94	0.5	0.89	0.62	1.0	0.67	0.62	0.94	0.63	0.74	0.93	0.56	0.63	0.77	0.77	0.83	0.1	0.59	0.71	0.78
Short Long Term Debt Total	0.96		0.84	0.8	0.91	0.93	0.99	0.46	0.86	0.61	0.96	0.77	0.61	0.91	0.58	0.76	0.87	0.58	0.6	0.82	0.67	0.85	0.23	0.59	0.68	0.85
Other Current Liab	0.78	0.84		0.92	0.69	0.78	0.85	0.21	0.81	0.42	0.77	0.86	0.43	0.85	0.55	0.55	0.74	0.58	0.56	0.73	0.59	0.71	0.39	0.53	0.65	0.84
Total Current Liabilities	0.73	0.8	0.92		0.64	0.73	0.83	0.19	0.76	0.27	0.72	0.93	0.27	0.84	0.52	0.43	0.73	0.49	0.5	0.67	0.58	0.63	0.67	0.53	0.61	0.89
Total Stockholder Equity	0.97	0.91	0.69	0.64		0.97	0.87	0.65	0.9	0.64	0.97	0.55	0.64	0.88	0.5	0.64	0.94	0.54	0.5	0.65	0.8	0.78	0.01	0.43	0.58	0.77
Property Plant And Equipment Net	0.99	0.93	0.78	0.73	0.97		0.91	0.5	0.93	0.58	0.98	0.67	0.58	0.95	0.59	0.67	0.97	0.51	0.58	0.71	0.84	0.79	0.08	0.53	0.69	0.78
Net Debt	0.94	0.99	0.85	0.83	0.87	0.91		0.41	0.83	0.46	0.94	0.82	0.47	0.93	0.59	0.73	0.87	0.49	0.6	0.82	0.67	0.79	0.32	0.64	0.68	0.84
Retained Earnings	0.5	0.46	0.21	0.19	0.65	0.5	0.41		0.59	0.45	0.5	0.04	0.45	0.3	-0.29	0.05	0.55	0.23	-0.23	0.05	0.56	0.3	-0.13	-0.31	-0.18	0.57
Accounts Payable	0.89	0.86	0.81	0.76	0.9	0.93	0.83	0.59		0.55	0.89	0.65	0.56	0.89	0.38	0.49	0.94	0.44	0.41	0.58	0.81	0.7	0.12	0.3	0.53	0.85
Cash	0.62	0.61	0.42	0.27	0.64	0.58	0.46	0.45	0.55		0.59	0.18	1.0	0.39	0.3	0.59	0.45	0.74	0.43	0.54	0.29	0.78	-0.26	0.17	0.41	0.48
Non Current Assets Total	1.0	0.96	0.77	0.72	0.97	0.98	0.94	0.5	0.89	0.59		0.67	0.59	0.94	0.63	0.74	0.93	0.52	0.62	0.77	0.76	0.81	0.11	0.6	0.7	0.77
Non Currrent Assets Other	0.67	0.77	0.86	0.93	0.55	0.67	0.82	0.04	0.65	0.18	0.67		0.18	0.81	0.58	0.49	0.66	0.43	0.57	0.7	0.47	0.6	0.64	0.61	0.66	0.77
Cash And Short Term Investments	0.62	0.61	0.43	0.27	0.64	0.58	0.47	0.45	0.56	1.0	0.59	0.18		0.39	0.3	0.59	0.45	0.74	0.43	0.54	0.29	0.78	-0.26	0.17	0.41	0.48
Net Receivables	0.94	0.91	0.85	0.84	0.88	0.95	0.93	0.3	0.89	0.39	0.94	0.81	0.39		0.69	0.67	0.94	0.41	0.65	0.76	0.78	0.73	0.27	0.67	0.77	0.77
Common Stock Shares Outstanding	0.63	0.58	0.55	0.52	0.5	0.59	0.59	-0.29	0.38	0.3	0.63	0.58	0.3	0.69		0.82	0.46	0.45	0.96	0.84	0.26	0.69	0.17	0.95	0.95	0.28
Non Current Liabilities Total	0.74	0.76	0.55	0.43	0.64	0.67	0.73	0.05	0.49	0.59	0.74	0.49	0.59	0.67	0.82		0.53	0.52	0.89	0.94	0.27	0.88	-0.04	0.83	0.86	0.38
Inventory	0.93	0.87	0.74	0.73	0.94	0.97	0.87	0.55	0.94	0.45	0.93	0.66	0.45	0.94	0.46	0.53		0.37	0.45	0.59	0.92	0.67	0.12	0.42	0.6	0.77
Other Current Assets	0.56	0.58	0.58	0.49	0.54	0.51	0.49	0.23	0.44	0.74	0.52	0.43	0.74	0.41	0.45	0.52	0.37		0.54	0.59	0.24	0.77	0.1	0.29	0.51	0.6
Other Stockholder Equity	0.63	0.6	0.56	0.5	0.5	0.58	0.6	-0.23	0.41	0.43	0.62	0.57	0.43	0.65	0.96	0.89	0.45	0.54		0.91	0.21	0.81	0.13	0.9	0.96	0.32
Total Liab	0.77	0.82	0.73	0.67	0.65	0.71	0.82	0.05	0.58	0.54	0.77	0.7	0.54	0.76	0.84	0.94	0.59	0.59	0.91		0.32	0.92	0.25	0.84	0.89	0.59
Property Plant And Equipment Gross	0.77	0.67	0.59	0.58	0.8	0.84	0.67	0.56	0.81	0.29	0.76	0.47	0.29	0.78	0.26	0.27	0.92	0.24	0.21	0.32		0.44	0.05	0.2	0.41	0.63
Total Current Assets	0.83	0.85	0.71	0.63	0.78	0.79	0.79	0.3	0.7	0.78	0.81	0.6	0.78	0.73	0.69	0.88	0.67	0.77	0.81	0.92	0.44		0.1	0.62	0.81	0.68
Short Term Debt	0.1	0.23	0.39	0.67	0.01	0.08	0.32	-0.13	0.12	-0.26	0.11	0.64	-0.26	0.27	0.17	-0.04	0.12	0.1	0.13	0.25	0.05	0.1		0.28	0.17	0.51
Intangible Assets	0.59	0.59	0.53	0.53	0.43	0.53	0.64	-0.31	0.3	0.17	0.6	0.61	0.17	0.67	0.95	0.83	0.42	0.29	0.9	0.84	0.2	0.62	0.28		0.88	0.27
Common Stock Total Equity	0.71	0.68	0.65	0.61	0.58	0.69	0.68	-0.18	0.53	0.41	0.7	0.66	0.41	0.77	0.95	0.86	0.6	0.51	0.96	0.89	0.41	0.81	0.17	0.88		0.4
Short Term Investments	0.78	0.85	0.84	0.89	0.77	0.78	0.84	0.57	0.85	0.48	0.77	0.77	0.48	0.77	0.28	0.38	0.77	0.6	0.32	0.59	0.63	0.68	0.51	0.27	0.4

Click cells to compare fundamentals

Boston Scientific Account Relationship Matchups

Boston Scientific fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	30.6B	30.8B	32.2B	32.5B	35.1B	36.9B
Short Long Term Debt Total	10.3B	9.5B	9.5B	9.3B	9.5B	10.0B
Other Current Liab	2.8B	2.9B	2.8B	2.5B	3.0B	3.1B
Total Current Liabilities	4.9B	3.7B	4.3B	3.8B	4.9B	5.2B
Total Stockholder Equity	13.9B	15.3B	16.6B	17.6B	19.3B	20.2B
Property Plant And Equipment Net	2.4B	2.5B	2.7B	2.8B	3.3B	3.5B
Net Debt	10.1B	7.8B	7.5B	8.4B	8.6B	9.1B
Retained Earnings	(2.3B)	(2.4B)	(1.4B)	(750M)	819M	860.0M
Accounts Payable	542M	513M	794M	862M	942M	989.1M
Non Current Assets Total	25.9B	24.1B	25.9B	26.7B	28.6B	30.1B
Non Currrent Assets Other	735M	545M	563M	707M	680M	714M
Net Receivables	1.9B	1.5B	1.8B	2.0B	2.2B	2.3B
Common Stock Shares Outstanding	1.4B	1.4B	1.4B	1.4B	1.5B	1.2B
Liabilities And Stockholders Equity	30.6B	30.8B	32.2B	32.5B	34.9B	36.6B
Non Current Liabilities Total	11.8B	11.8B	11.3B	11.1B	10.7B	6.2B
Inventory	1.6B	1.4B	1.6B	1.9B	2.5B	2.6B
Other Current Assets	324M	2.1B	1.0B	995M	937M	544.2M
Other Stockholder Equity	15.8B	17.5B	17.7B	18.0B	18.4B	10.0B
Total Liab	16.7B	15.5B	15.6B	14.9B	15.6B	8.6B
Property Plant And Equipment Gross	2.4B	2.5B	2.3B	2.4B	6.8B	7.1B
Total Current Assets	4.7B	6.7B	6.3B	5.8B	6.5B	3.3B
Accumulated Other Comprehensive Income	270M	207M	263M	269M	49M	51.5M
Short Term Debt	1.4B	13M	261M	20M	531M	417.5M
Intangible Assets	7.9B	5.9B	6.1B	5.9B	6.0B	4.9B
Other Liab	3.0B	2.2B	2.1B	1.8B	2.1B	1.9B
Other Assets	(2M)	4.6B	3M	2M	(1M)	950K
Long Term Debt	8.6B	9.1B	8.8B	8.9B	8.6B	5.6B
Good Will	10.2B	10.0B	12.0B	12.9B	14.4B	8.6B
Property Plant Equipment	2.1B	2.1B	2.3B	2.8B	3.3B	1.7B
Current Deferred Revenue	144M	138M	208M	220M	266M	333.1M
Net Tangible Assets	(4.2B)	9.4B	(1.7B)	11.7B	13.4B	14.1B
Retained Earnings Total Equity	(2.3B)	(2.4B)	(1.4B)	(750M)	(862.5M)	(905.6M)
Long Term Debt Total	8.6B	9.1B	8.8B	8.9B	10.3B	6.6B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boston Operating Income vs Total Operating Expenses Analysis

Operating Income vs Total Operating Expenses

Operating Income vs Total Operating Expenses Correlation Analysis

Correlation Coefficient

Operating Income

Total Operating Expenses

Boston Scientific fundamental ratios Correlations

Boston Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Boston Scientific fundamental ratios Accounts

Also Currently Popular

Additional Tools for Boston Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Net	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.98	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.97	Total Assets

Intangible Assets	- 0.31	Retained Earnings
Common Stock Shares Outstanding	- 0.29	Retained Earnings
Short Term Debt	- 0.26	Cash And Short Term Investments
Short Term Debt	- 0.26	Cash
Other Stockholder Equity	- 0.23	Retained Earnings
Common Stock Total Equity	- 0.18	Retained Earnings